134 related articles for article (PubMed ID: 9257379)
41. Effect of myristyl nicotinate on retinoic acid therapy for facial photodamage.
Jacobson MK; Kim H; Coyle WR; Kim M; Coyle DL; Rizer RL; Jacobson EL
Exp Dermatol; 2007 Nov; 16(11):927-35. PubMed ID: 17927576
[TBL] [Abstract][Full Text] [Related]
42. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
Grimes P; Watson J
Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
[TBL] [Abstract][Full Text] [Related]
43. Topical tretinoin: photodamage treatment overview and developmental toxicology studies. Introduction.
Gilchrest BA; Holmes LB
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 2):S25-6. PubMed ID: 9091505
[No Abstract] [Full Text] [Related]
44. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
[TBL] [Abstract][Full Text] [Related]
46. Topical retinoic acid (tretinoin) for photoaging: conceptions and misperceptions.
Kligman AM
Cutis; 1996 Mar; 57(3):142-4. PubMed ID: 8882009
[No Abstract] [Full Text] [Related]
47. High-strength tretinoin for rapid retinization of photoaged facial skin.
Kligman DE; Draelos ZD
Dermatol Surg; 2004 Jun; 30(6):864-6. PubMed ID: 15171763
[TBL] [Abstract][Full Text] [Related]
48. Two concentrations of topical tretinoin (retinoic acid) cause similar improvement of photoaging but different degrees of irritation. A double-blind, vehicle-controlled comparison of 0.1% and 0.025% tretinoin creams.
Griffiths CE; Kang S; Ellis CN; Kim KJ; Finkel LJ; Ortiz-Ferrer LC; White GM; Hamilton TA; Voorhees JJ
Arch Dermatol; 1995 Sep; 131(9):1037-44. PubMed ID: 7544967
[TBL] [Abstract][Full Text] [Related]
49. Diffuse Reflectance Spectroscopy as a Reliable Means of Comparing Ultraviolet Radiation-induced Erythema in Extreme Skin Colors.
Fajuyigbe D; Coleman A; Sarkany RPE; Young AR; Schmalwieser AW
Photochem Photobiol; 2018 Sep; 94(5):1066-1070. PubMed ID: 29869793
[TBL] [Abstract][Full Text] [Related]
50. Tretinoin and cutaneous photoaging. Guaranteed adverse effects!
Can Fam Physician; 2000 Apr; 46():828-30, 832-4. PubMed ID: 10790815
[TBL] [Abstract][Full Text] [Related]
51. Benefits of using a hydroquinone/tretinoin skin care system in patients undergoing intense pulsed light therapy for photorejuvenation: a placebo-controlled study.
Woodhall KE; Goldman MP; Gold MH; Biron J
J Drugs Dermatol; 2009 Sep; 8(9):862-7. PubMed ID: 19746679
[TBL] [Abstract][Full Text] [Related]
52. Treatment of photodamaged facial skin with topical tretinoin.
Leyden JJ; Grove GL; Grove MJ; Thorne EG; Lufrano L
J Am Acad Dermatol; 1989 Sep; 21(3 Pt 2):638-44. PubMed ID: 2674225
[TBL] [Abstract][Full Text] [Related]
53. Tretinoin cream 0.02% for the treatment of photodamaged facial skin: a review of 2 double-blind clinical studies.
Nyirady J; Bergfeld W; Ellis C; Levine N; Savin R; Shavin J; Voorhees JJ; Weiss J; Grossman R
Cutis; 2001 Aug; 68(2):135-42. PubMed ID: 11534915
[TBL] [Abstract][Full Text] [Related]
54. Tretinoin and cutaneous photoageing: new preparation. Guaranteed adverse effects!
Prescrire Int; 1999 Oct; 8(43):139-40. PubMed ID: 11503837
[TBL] [Abstract][Full Text] [Related]
55. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double-blind, randomized, parallel-group study.
Lowe N; Gifford M; Tanghetti E; Poulin Y; Goldman M; Tse Y; Yamauchi P; Rosenzweig H; Kang S
J Cosmet Laser Ther; 2004 Jun; 6(2):79-85. PubMed ID: 15203997
[TBL] [Abstract][Full Text] [Related]
56. Facilitating facial retinization through barrier improvement.
Draelos ZD; Ertel KD; Berge CA
Cutis; 2006 Oct; 78(4):275-81. PubMed ID: 17121065
[TBL] [Abstract][Full Text] [Related]
57. Effects of p-coumaric acid on erythema and pigmentation of human skin exposed to ultraviolet radiation.
Seo YK; Kim SJ; Boo YC; Baek JH; Lee SH; Koh JS
Clin Exp Dermatol; 2011 Apr; 36(3):260-6. PubMed ID: 21198798
[TBL] [Abstract][Full Text] [Related]
58. Minimum erythema dose determination in individuals of skin type V and VI with diffuse reflectance spectroscopy.
Kollias N; Baqer A; Sadiq I
Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):249-54. PubMed ID: 7727281
[TBL] [Abstract][Full Text] [Related]
59. Quantitative skin color measurements in acanthosis nigricans patients: colorimetry and diffuse reflectance spectroscopy.
Pattamadilok B; Devpura S; Syed ZU; Agbai ON; Vemulapalli P; Henderson M; Rehse SJ; Mahmoud BH; Lim HW; Naik R; Hamzavi IH
Photodermatol Photoimmunol Photomed; 2012 Aug; 28(4):213-5. PubMed ID: 23017175
[TBL] [Abstract][Full Text] [Related]
60. Pretreatment of photoaged forearm skin with topical tretinoin accelerates healing of full-thickness wounds.
Popp C; Kligman AM; Stoudemayer TJ
Br J Dermatol; 1995 Jan; 132(1):46-53. PubMed ID: 7756151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
